Aster DM Healthcare working capital

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

31.93×	31.93×	39.46×	282.19×	120.47×	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
22.21×	22.21×	21.66×	126.78×	66.63×
157.95×	157.95×	172.11×	686.76×	263.84×
−103.81×	−103.81×	−110.99×	−277.79×	−76.74×
5.03×	4.79×	4.05×	−12.08×	44.81×
0.63×	0.63×	0.34×	0.23×	0.87×
1.54×	1.54×	0.08×	0.75×	3.86×
0.73×	0.73×	0.56×	0.27×	1.17×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ASTERDM₹650.00

Aster DM Healthcare Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH KIMS COHANCE WOCKPHARMA SYNGENE GLAND LALPATHLABMcap ₹33,678 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Inventory Days (DIO)	120.47	282.19	39.46	31.93	31.93
Receivable Days (DSO)	66.63	126.78	21.66	22.21	22.21
Payable Days (DPO)	263.84	686.76	172.11	157.95	157.95
Cash Conversion Cycle (days)	-76.74	-277.79	-110.99	-103.81	-103.81
Working Capital Turnover	44.81	-12.08	4.05	4.79	5.03
Asset Turnover	0.87	0.23	0.34	0.63	0.63
Cash Conversion (CFO/Net Income)	3.86	0.75	0.08	1.54	1.54
CFO/EBITDA	1.17	0.27	0.56	0.73	0.73

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.